{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:39:36Z","timestamp":1789785576333,"version":"4.0.1"},"reference-count":115,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000082","name":"National Science Foundation Division of Graduate Education","doi-asserted-by":"publisher","award":["DGE 2022168"],"award-info":[{"award-number":["DGE 2022168"]}],"id":[{"id":"10.13039\/100000082","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000165","name":"National Science Foundation Division of Chemistry","doi-asserted-by":"publisher","award":["CHE 2109255"],"award-info":[{"award-number":["CHE 2109255"]}],"id":[{"id":"10.13039\/100000165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jbc.2024.107858","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T02:14:43Z","timestamp":1728094483000},"page":"107858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The unique Pt(II)-induced nucleolar stress response and its deviation from DNA damage response pathways"],"prefix":"10.1016","volume":"300","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5761-671X","authenticated-orcid":false,"given":"Hannah C.","family":"Pigg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4757-6408","authenticated-orcid":false,"given":"Katelyn R.","family":"Alley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3481-2068","authenticated-orcid":false,"given":"Christopher R.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleb H.","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9304-7192","authenticated-orcid":false,"given":"Sarah J.","family":"Kraske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6881-0626","authenticated-orcid":false,"given":"Victoria J.","family":"DeRose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2024.107858_bib1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ctrv.2007.01.009","article-title":"Oxaliplatin for the treatment of cisplatin-resistant cancer: a systematic review","volume":"33","author":"Stordal","year":"2007","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.jbc.2024.107858_bib2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s10120-011-0007-7","article-title":"Effectiveness and safety of oxaliplatin compared to cisplatin for advanced, unresectable gastric cancer: a systematic review and meta-analysis","volume":"14","author":"Montagnani","year":"2011","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.jbc.2024.107858_bib3","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0006-2952(97)81490-6","article-title":"Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute\u2019s Anticancer Drug Screen panel","volume":"52","author":"Rixe","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jbc.2024.107858_bib4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nm.4291","article-title":"A\u00a0subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress","volume":"23","author":"Bruno","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.jbc.2024.107858_bib5","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1021\/acschembio.2c00399","article-title":"Time-dependent studies of oxaliplatin and other nucleolar stress-inducing Pt(II) derivatives","volume":"17","author":"Pigg","year":"2022","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107858_bib6","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.3390\/cancers14092126","article-title":"Targeting ribosome biogenesis in cancer: lessons learned and way forward","volume":"14","author":"Zisi","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbc.2024.107858_bib7","doi-asserted-by":"crossref","first-page":"RP88799","DOI":"10.7554\/eLife.88799","article-title":"Distinct states of nucleolar stress induced by anticancer drugs","volume":"12","author":"Potapova","year":"2023","journal-title":"eLife"},{"key":"10.1016\/j.jbc.2024.107858_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jprot.2017.05.005","article-title":"Proteomic profiling reveals DNA damage, nucleolar and ribosomal stress are the main responses to oxaliplatin treatment in cancer cells","volume":"162","author":"Ozdian","year":"2017","journal-title":"J.\u00a0Proteomics"},{"key":"10.1016\/j.jbc.2024.107858_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a000745","article-title":"DNA damage response","volume":"3","author":"Giglia-Mari","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.jbc.2024.107858_bib10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/em.22087","article-title":"Mechanisms of DNA damage, repair and mutagenesis","volume":"58","author":"Chatterjee","year":"2017","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.jbc.2024.107858_bib11","first-page":"1","article-title":"DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy","volume":"6","author":"Huang","year":"2021","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.jbc.2024.107858_bib12","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.3390\/ijms24054741","article-title":"DNA damage and its role in cancer therapeutics","volume":"24","author":"Moon","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2024.107858_bib13","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3390\/cancers12041050","article-title":"DNA damage\/repair management in cancers","volume":"12","author":"Alhmoud","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbc.2024.107858_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314672","article-title":"DNA damage response in cancer therapy and resistance: challenges and opportunities","volume":"23","author":"Jurkovicova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2024.107858_bib15","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.3390\/ijms23031701","article-title":"Therapeutic targeting of DNA damage response in cancer","volume":"23","author":"Choi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2024.107858_bib16","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/cas.12366","article-title":"Targeting DNA damage response in cancer therapy","volume":"105","author":"Hosoya","year":"2014","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jbc.2024.107858_bib17","article-title":"Cellular responses to cisplatin-induced DNA damage","volume":"2010","author":"Basu","year":"2010","journal-title":"J.\u00a0Nucleic Acids"},{"key":"10.1016\/j.jbc.2024.107858_bib18","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1039\/b907567d","article-title":"Inhibition of transcription by platinum antitumor compounds","volume":"1","author":"Todd","year":"2009","journal-title":"Metallomics"},{"key":"10.1016\/j.jbc.2024.107858_bib19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrd1691","article-title":"Cellular processing of platinum anticancer drugs","volume":"4","author":"Wang","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jbc.2024.107858_bib20","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1158\/1535-7163.MCT-19-0133","article-title":"Oxaliplatin\u2013DNA adducts as predictive biomarkers of FOLFOX response in colorectal cancer: a potential treatment optimization strategy","volume":"19","author":"Zimmermann","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jbc.2024.107858_bib21","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1021\/acs.chemrestox.8b00170","article-title":"Correlation of platinum cytotoxicity to drug-DNA adduct levels in a breast cancer cell line panel","volume":"31","author":"Wang","year":"2018","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jbc.2024.107858_bib22","series-title":"Platinum-Based Drugs in Cancer Therapy","first-page":"129","article-title":"DNA adduct tolerance and bypass","author":"Chaney","year":"2000"},{"key":"10.1016\/j.jbc.2024.107858_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.critrevonc.2004.08.008","article-title":"Recognition and processing of cisplatin- and oxaliplatin-DNA adducts","volume":"53","author":"Chaney","year":"2005","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.jbc.2024.107858_bib24","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1124\/mol.54.5.770","article-title":"Sequence- and region-specificity of oxaliplatin adducts in naked and cellular DNA","volume":"54","author":"Woynarowski","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jbc.2024.107858_bib25","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1124\/mol.58.5.920","article-title":"Oxaliplatin-induced damage of cellular DNA","volume":"58","author":"Woynarowski","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jbc.2024.107858_bib26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0006-2952(03)00260-0","article-title":"DNA strand breaks and apoptosis induced by oxaliplatin in cancer cells","volume":"66","author":"Faivre","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jbc.2024.107858_bib27","first-page":"227","article-title":"Cellular and molecular pharmacology of oxaliplatin","volume":"1","author":"Raymond","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jbc.2024.107858_bib28","doi-asserted-by":"crossref","DOI":"10.6061\/clinics\/2018\/e478s","article-title":"DNA repair pathways and cisplatin resistance: an intimate relationship","volume":"73","author":"Rocha","year":"2018","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.jbc.2024.107858_bib29","doi-asserted-by":"crossref","first-page":"6928","DOI":"10.3390\/ijms21186928","article-title":"Comparative study of the mode of action of clinically approved platinum-based chemotherapeutics","volume":"21","author":"Schoch","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2024.107858_bib30","first-page":"3968","article-title":"Efficient nucleotide excision repair of cisplatin, oxaliplatin, and Bis-aceto-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) platinum intrastrand DNA diadducts","volume":"59","author":"Reardon","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2024.107858_bib31","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1158\/1078-0432.CCR-07-2238","article-title":"Platinum resistance: the role of DNA repair pathways","volume":"14","author":"Martin","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2024.107858_bib32","doi-asserted-by":"crossref","first-page":"12416","DOI":"10.1074\/jbc.M109.074211","article-title":"Chemotherapeutic drugs inhibit ribosome biogenesis at various levels","volume":"285","author":"Burger","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107858_bib33","first-page":"290","volume":"59","author":"Koba","year":"2005","journal-title":"Postepy Hig. Med. Dosw. (Online)"},{"key":"10.1016\/j.jbc.2024.107858_bib34","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1242\/jcs.111948","article-title":"Eukaryotic ribosome biogenesis at a glance","volume":"126","author":"Thomson","year":"2013","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.jbc.2024.107858_bib35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0074-7696(02)19014-0","article-title":"Conventional and nonconventional roles of the nucleolus","volume":"219","author":"Olson","year":"2002","journal-title":"Int. Rev. Cytol."},{"key":"10.1016\/j.jbc.2024.107858_bib36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-319-38882-3_2","article-title":"The nucleolus: structure and function","author":"Dubois","year":"2016","journal-title":"Funct. Nucl."},{"key":"10.1016\/j.jbc.2024.107858_bib37","doi-asserted-by":"crossref","first-page":"18411","DOI":"10.1021\/jacs.9b10319","article-title":"Nucleolar stress induction by oxaliplatin and derivatives","volume":"141","author":"Sutton","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2024.107858_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100633","article-title":"Early nucleolar responses differentiate mechanisms of cell death induced by oxaliplatin and cisplatin","volume":"296","author":"Sutton","year":"2021","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107858_bib39","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00775-019-01707-9","article-title":"Monofunctional platinum(II) compounds and nucleolar stress: is phenanthriplatin unique?","volume":"24","author":"McDevitt","year":"2019","journal-title":"J.\u00a0Biol. Inorg. Chem."},{"key":"10.1016\/j.jbc.2024.107858_bib40","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1039\/D3CB00055A","article-title":"Comparison of click-capable oxaliplatin and cisplatin derivatives to better understand Pt(II)-induced nucleolar stress","volume":"4","author":"Guerrero","year":"2023","journal-title":"RSC Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107858_bib41","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1021\/acschembio.3c00607","article-title":"Click-capable phenanthriplatin derivatives as tools to study Pt(II)-Induced nucleolar stress","volume":"19","author":"O\u2019Dowd","year":"2024","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107858_bib42","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.chembiol.2023.06.010","article-title":"Inhibition of nucleolar transcription by oxaliplatin involves ATM\/ATR kinase signaling","volume":"30","author":"Nechay","year":"2023","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107858_bib43","article-title":"Oxaliplatin disrupts nucleolar function through biophysical disintegration","volume":"41","author":"Broder Schmidt","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.jbc.2024.107858_bib44","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12859-022-04590-5","article-title":"DrugShot: querying biomedical search terms to retrieve prioritized lists of small molecules","volume":"23","author":"Kropiwnicki","year":"2022","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jbc.2024.107858_bib45","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s12906-016-1396-2","article-title":"Aqueous extract of Lithospermi radix attenuates oxaliplatin-induced neurotoxicity in both in\u00a0vitro and in\u00a0vivo models","volume":"16","author":"Cho","year":"2016","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.jbc.2024.107858_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/or.2022.8289","article-title":"ATR inhibitor AZD6738 increases the sensitivity of colorectal cancer cells to 5-fluorouracil by inhibiting repair of DNA damage","volume":"47","author":"Suzuki","year":"2022","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jbc.2024.107858_bib47","first-page":"256","article-title":"Review of cisplatin and oxaliplatin in current immunogenic and monoclonal antibody treatments","volume":"8","author":"Mehmood","year":"2014","journal-title":"Oncol. Rev."},{"key":"10.1016\/j.jbc.2024.107858_bib48","doi-asserted-by":"crossref","DOI":"10.1093\/narcan\/zcad057","article-title":"Detection of oxaliplatin- and cisplatin-DNA lesions requires different global genome repair mechanisms that affect their clinical efficacy","volume":"5","author":"Slyskova","year":"2023","journal-title":"NAR Cancer"},{"key":"10.1016\/j.jbc.2024.107858_bib49","doi-asserted-by":"crossref","first-page":"8199","DOI":"10.3390\/ijms22158199","article-title":"Targeting DNA damage response and repair to enhance therapeutic index in cisplatin-based cancer treatment","volume":"22","author":"Kiss","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2024.107858_bib50","doi-asserted-by":"crossref","first-page":"14564","DOI":"10.1074\/jbc.M111.225375","article-title":"Novel role of base excision repair in mediating cisplatin cytotoxicity","volume":"286","author":"Kothandapani","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107858_bib51","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1007\/s00018-014-1666-4","article-title":"Functional interplay between ATM\/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress","volume":"71","author":"Yan","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jbc.2024.107858_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159344","article-title":"ATR- and ATM-mediated DNA damage response is dependent on excision repair assembly during G1 but not in S phase of cell cycle","volume":"11","author":"Ray","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2024.107858_bib53","first-page":"73","article-title":"Chapter 3 - the ATM\u2013Chk2 and ATR\u2013Chk1 pathways in DNA damage signaling and cancer","volume":"108","author":"Smith","year":"2010"},{"key":"10.1016\/j.jbc.2024.107858_bib54","article-title":"H2AX phosphorylation: its role in DNA damage response and cancer therapy","volume":"2010","author":"Podhorecka","year":"2010","journal-title":"J.\u00a0Nucleic Acids"},{"key":"10.1016\/j.jbc.2024.107858_bib55","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1158\/1541-7786.MCR-20-0396","article-title":"Platinum-induced ubiquitination of phosphorylated H2AX by RING1A is mediated by replication protein A in ovarian cancer","volume":"18","author":"Sriramkumar","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jbc.2024.107858_bib56","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2015808118","article-title":"ACTL6A promotes repair of cisplatin-induced DNA damage, a new mechanism of platinum resistance in cancer","volume":"118","author":"Xiao","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.107858_bib57","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/leu.2010.6","article-title":"\u03b3H2AX: a sensitive molecular marker of DNA damage and repair","volume":"24","author":"Mah","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.jbc.2024.107858_bib58","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00412-009-0234-4","article-title":"H2AX: functional roles and potential applications","volume":"118","author":"Dickey","year":"2009","journal-title":"Chromosoma"},{"key":"10.1016\/j.jbc.2024.107858_bib59","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1595\/147106708X255987","article-title":"Metal-ligand exchange kinetics in platinum and ruthenium complexes","volume":"52","author":"Reedijk","year":"2008","journal-title":"Platinum Met. Rev"},{"key":"10.1016\/j.jbc.2024.107858_bib60","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.dib.2017.03.023","article-title":"Changes in cellular signaling proteins in extracts from A549, H460, and U2OS cells treated with cisplatin or docetaxel","volume":"12","author":"Petrovic","year":"2017","journal-title":"Data Brief"},{"key":"10.1016\/j.jbc.2024.107858_bib61","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202305008","article-title":"Cell growth and nutrient availability control the mitotic exit signaling network in budding yeast","volume":"223","author":"Talavera","year":"2024","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.jbc.2024.107858_bib62","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1091\/mbc.E19-09-0515","article-title":"The effects of proliferation status and cell cycle phase on the responses of single cells to chemotherapy","volume":"31","author":"Granada","year":"2020","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jbc.2024.107858_bib63","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1038\/s41467-023-39332-5","article-title":"ATR kinase supports normal proliferation in the early S phase by preventing replication resource exhaustion","volume":"14","author":"Menolfi","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2024.107858_bib64","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41568-018-0034-3","article-title":"Targeting ATR in cancer","volume":"18","author":"Lecona","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jbc.2024.107858_bib65","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s10020-024-00821-y","article-title":"Bleomycin induces senescence and repression of DNA repair via downregulation of Rad51","volume":"30","author":"Chen","year":"2024","journal-title":"Mol. Med."},{"key":"10.1016\/j.jbc.2024.107858_bib66","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.tranon.2017.01.007","article-title":"ATM-deficient colorectal cancer cells are sensitive to the PARP inhibitor olaparib","volume":"10","author":"Wang","year":"2017","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.jbc.2024.107858_bib67","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3389\/fphar.2015.00147","article-title":"Simultaneous inhibition of ATR and PARP sensitizes colon cancer cell lines to irinotecan","volume":"6","author":"Abu-Sanad","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jbc.2024.107858_bib68","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/nar\/gkab1231","article-title":"Early rRNA processing is a stress-dependent regulatory event whose inhibition maintains nucleolar integrity","volume":"50","author":"Szaflarski","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2024.107858_bib69","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2144\/04361RR04","article-title":"Estimation of ribosomal RNA transcription rate in situ","volume":"36","author":"Cui","year":"2004","journal-title":"Biotechniques"},{"key":"10.1016\/j.jbc.2024.107858_bib70","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/embor.2009.271","article-title":"Polyadenylation and degradation of incomplete RNA polymerase I transcripts in mammalian cells","volume":"11","author":"Shcherbik","year":"2010","journal-title":"EMBO Rep."},{"key":"10.1016\/j.jbc.2024.107858_bib71","doi-asserted-by":"crossref","first-page":"9449","DOI":"10.1093\/nar\/gkaa713","article-title":"Recent advances in the nucleolar responses to DNA double-strand breaks","volume":"48","author":"Korsholm","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2024.107858_bib72","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.molcel.2010.09.024","article-title":"The nucleolus under stress","volume":"40","author":"Boulon","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2024.107858_bib73","doi-asserted-by":"crossref","first-page":"125","DOI":"10.15698\/cst2018.06.139","article-title":"Nucleolar stress: hallmarks, sensing mechanism and diseases","volume":"2","author":"Yang","year":"2018","journal-title":"Cell Stress"},{"key":"10.1016\/j.jbc.2024.107858_bib74","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/bs.apcsb.2023.01.001","article-title":"The role of the nucleolus in regulating the cell cycle and the DNA damage response","volume":"135","author":"Sakthivel","year":"2023","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"10.1016\/j.jbc.2024.107858_bib75","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1158\/1535-7163.MCT-05-0212","article-title":"Repression of cell cycle\u2013related proteins by oxaliplatin but not cisplatin in human colon cancer cells","volume":"5","author":"Voland","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jbc.2024.107858_bib76","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.bcp.2007.05.001","article-title":"p53 dependent and independent sensitivity to oxaliplatin of colon cancer cells","volume":"74","author":"Toscano","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jbc.2024.107858_bib77","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1038\/sj.bjc.6602215","article-title":"Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells","volume":"91","author":"Arango","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jbc.2024.107858_bib78","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1158\/1535-7163.MCT-05-0011","article-title":"Role of p21waf1\/cip1 in effects of oxaliplatin in colorectal cancer cells","volume":"4","author":"Hata","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jbc.2024.107858_bib79","doi-asserted-by":"crossref","first-page":"37139","DOI":"10.1074\/jbc.M307088200","article-title":"Caffeine inhibits checkpoint responses without inhibiting the ataxia-telangiectasia-mutated (ATM) and ATM- and\u00a0Rad3-related (ATR) protein kinases","volume":"278","author":"Cortez","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107858_bib80","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1038\/s41416-022-01946-9","article-title":"CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer","volume":"127","author":"Hsieh","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jbc.2024.107858_bib81","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1091\/mbc.E23-02-0062","article-title":"Nucleolar structure connects with global nuclear organization","volume":"34","author":"Wang","year":"2023","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jbc.2024.107858_bib82","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1091\/mbc.e04-11-0992","article-title":"Dynamic sorting of nuclear components into distinct nucleolar caps during transcriptional inhibition","volume":"16","author":"Shav-Tal","year":"2005","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jbc.2024.107858_bib83","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.210305","article-title":"A\u00a0high-throughput assay for directly monitoring nucleolar rRNA biogenesis","volume":"12","author":"Bryant","year":"2022","journal-title":"Open Biol."},{"key":"10.1016\/j.jbc.2024.107858_bib115","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pathol.2016.11.002","article-title":"DNA damage repair in breast cancer and its therapeutic implications","volume":"49","author":"Ali","year":"2017","journal-title":"Pathology"},{"key":"10.1016\/j.jbc.2024.107858_bib84","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3390\/cancers11101429","article-title":"The targeting of RNA polymerase I transcription using CX-5461 in combination with radiation enhances tumour cell killing effects in human solid cancers","volume":"11","author":"Ismael","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbc.2024.107858_bib85","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1158\/1535-7163.MCT-14-0256","article-title":"Small molecule BMH-compounds that inhibit RNA polymerase I and cause nucleolar stress","volume":"13","author":"Peltonen","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jbc.2024.107858_bib86","first-page":"1904","article-title":"Actinomycin D inhibits cell proliferations and promotes apoptosis in osteosarcoma cells","volume":"8","author":"Lu","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.jbc.2024.107858_bib87","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.18632\/oncotarget.2020","article-title":"DNA intercalator BMH-21 inhibits RNA polymerase I independent of DNA damage response","volume":"5","author":"Colis","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2024.107858_bib88","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.3390\/cancers13205056","article-title":"CX-5461 treatment leads to cytosolic DNA-mediated STING activation in ovarian cancer","volume":"13","author":"Cornelison","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbc.2024.107858_bib89","first-page":"812","article-title":"DNA intercalators and using them as anticancer drugs","volume":"2","author":"Goftar","year":"2014","journal-title":"Int. J. Adv. Biol. Biomed. Res."},{"key":"10.1016\/j.jbc.2024.107858_bib90","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ijc.2910240115","article-title":"Actinomycin D restores in\u00a0vivo sensitivity to differentiation induction of non-differentiating mouse myeloid leukemia cells","volume":"24","author":"Okabe","year":"1979","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jbc.2024.107858_bib91","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2013.12.009","article-title":"A\u00a0targeting modality for destruction of RNA polymerase I that possesses anticancer activity","volume":"25","author":"Peltonen","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbc.2024.107858_bib92","article-title":"The small-molecule BMH-21 directly inhibits transcription elongation and DNA occupancy of RNA polymerase I in\u00a0vivo and in\u00a0vitro","volume":"298","author":"Jacobs","year":"2021","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107858_bib93","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.celrep.2018.03.066","article-title":"Small-molecule targeting of RNA polymerase I activates a conserved transcription elongation checkpoint","volume":"23","author":"Wei","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.jbc.2024.107858_bib94","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1073\/pnas.1921649117","article-title":"The primary mechanism of cytotoxicity of the chemotherapeutic agent CX-5461 is topoisomerase II poisoning","volume":"117","author":"Bruno","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.107858_bib95","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1038\/s41467-020-16393-4","article-title":"CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer","volume":"11","author":"Sanij","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2024.107858_bib96","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1038\/s41467-021-26640-x","article-title":"The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma","volume":"12","author":"Pan","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2024.107858_bib97","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1158\/2159-8290.CD-18-1455","article-title":"First-in-Human RNA polymerase I transcription inhibitor CX-5461 in patients with advanced hematologic cancers: results of a phase I dose-escalation study","volume":"9","author":"Khot","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jbc.2024.107858_bib98","doi-asserted-by":"crossref","DOI":"10.1093\/narcan\/zcaa032","article-title":"The chemotherapeutic agent CX-5461 irreversibly blocks RNA polymerase I initiation and promoter release to cause nucleolar disruption, DNA damage and cell inviability","volume":"2","author":"Mars","year":"2020","journal-title":"NAR Cancer"},{"key":"10.1016\/j.jbc.2024.107858_bib99","first-page":"5987","article-title":"Short exposure to actinomycin D induces \u201creversible\u201d translocation of protein B23 as well as \u201creversible\u201d inhibition of cell growth and RNA synthesis in HeLa cells","volume":"50","author":"Yung","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2024.107858_bib100","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-17923-4","article-title":"CX-5461 causes nucleolar compaction, alteration of peri- and intranucleolar chromatin arrangement, an increase in both heterochromatin and DNA damage response","volume":"12","author":"Snyers","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2024.107858_bib101","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1093\/nar\/gkae069","article-title":"Chromatin damage generated by DNA intercalators leads to degradation of RNA Polymerase II","volume":"52","author":"Espinoza","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2024.107858_bib102","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.3390\/genes12081156","article-title":"Harnessing the nucleolar DNA damage response in cancer therapy","volume":"12","author":"Xuan","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.jbc.2024.107858_bib103","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.4161\/cc.28605","article-title":"ATM-dependent E2F1 accumulation in the nucleolus is an indicator of ribosomal stress in early response to DNA damage","volume":"13","author":"Jin","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jbc.2024.107858_bib104","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.clcc.2018.09.001","article-title":"ATM is required for the repair of oxaliplatin-induced DNA damage in colorectal cancer","volume":"17","author":"Bakkenist","year":"2018","journal-title":"Clin. Colorectal Cancer"},{"key":"10.1016\/j.jbc.2024.107858_bib105","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.clcc.2018.05.011","article-title":"Ataxia telangiectasia mutated protein loss and benefit from oxaliplatin-based chemotherapy in colorectal cancer","volume":"17","author":"Sundar","year":"2018","journal-title":"Clin. Colorectal Cancer"},{"key":"10.1016\/j.jbc.2024.107858_bib106","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/cbic.202200130","article-title":"Influence of ring modifications on nucleolar stress caused by oxaliplatin-like compounds","volume":"23","author":"McDevitt","year":"2022","journal-title":"Chembiochem"},{"key":"10.1016\/j.jbc.2024.107858_bib107","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jinorgbio.2018.09.007","volume":"189","author":"Cunningham","year":"2018","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.jbc.2024.107858_bib108","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/cells7100157","article-title":"Crosstalk between NF-\u03baB and nucleoli in the regulation of cellular homeostasis","volume":"7","author":"Chen","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.jbc.2024.107858_bib109","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3390\/biomedicines9091082","article-title":"The NF-\u03baB nucleolar stress response pathway","volume":"9","author":"Thoms","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.jbc.2024.107858_bib110","doi-asserted-by":"crossref","first-page":"21392","DOI":"10.3390\/ijms160921392","article-title":"Cisplatin targeting of bacterial ribosomal RNA hairpins","volume":"16","author":"Dedduwa-Mudalige","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2024.107858_bib111","first-page":"109","article-title":"A\u00a0new role for cisplatin: probing ribosomal RNA structure","volume":"1","author":"Rijal","year":"2008","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jbc.2024.107858_bib112","doi-asserted-by":"crossref","first-page":"12746","DOI":"10.1039\/C7CC06708A","article-title":"Mapping platinum adducts on yeast ribosomal RNA using high-throughput sequencing","volume":"53","author":"Plakos","year":"2017","journal-title":"Chem. Commun. (Camb)"},{"key":"10.1016\/j.jbc.2024.107858_bib113","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1021\/cb500395z","article-title":"Platinum-RNA modifications following drug treatment in S.\u00a0cerevisiae identified by click chemistry and enzymatic mapping","volume":"9","author":"Osborn","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107858_bib114","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00775-019-01693-y","article-title":"Amino acid-linked platinum(II) compounds: non-canonical nucleoside preferences and influence on glycosidic bond stabilities","volume":"24","author":"Kimutai","year":"2019","journal-title":"J.\u00a0Biol. Inorg. Chem."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925824023603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925824023603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T15:53:10Z","timestamp":1732809190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925824023603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":115,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0021925824023603"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2024.107858","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.06.05.597606","asserted-by":"object"}]},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The unique Pt(II)-induced nucleolar stress response and its deviation from DNA damage response pathways","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2024.107858","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"107858"}}